Intravenous gamma globulins in Kawasaki disease.

被引:0
|
作者
Astruc, J [1 ]
机构
[1] Hop Arnaud de Villeneuve, Serv Pediat, F-34295 Montpellier 5, France
来源
关键词
Kawasaki disease; intravenous immunoglobulins; immunomodulation;
D O I
10.1016/S0399-077X(98)90009-9
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Furusho, in 1983 and 1984, was the first to cure Kawasaki disease (KD) by using polyvalent intravenous immunoglobulins (IV Ig). TV Ig have now become the first line treatment for KD and they bring about a dramatic improvement in the acute phase and prevention of coronary alterations. How work IV Ig work is a complex question: specific neutralization of anti-endothelial antoantibodies can be postulated. But the main mechanism is probably immunomodulation mediated not only by the Fc portion of IV Ig, but also by numerous antibodies specifically directed against molecules of immune activation found in commercial preparations of IV Ig.
引用
收藏
页码:586 / 589
页数:4
相关论文
共 50 条
  • [31] RAPID REGRESSION OF CORONARY DILATATION IN KAWASAKI-DISEASE WITH INTRAVENOUS GAMMA-GLOBULIN
    SAALOUKE, MG
    VENGLARCIK, JS
    BAKER, DR
    SAALOUKE, ZI
    BASHOUR, TT
    AMERICAN HEART JOURNAL, 1991, 121 (03) : 905 - 909
  • [32] Efficacy of plasma exchange therapy for Kawasaki disease intractable to intravenous gamma-globulin.
    Mori, M
    Imagawa, T
    Katakura, S
    Miyamae, T
    Yokota, S
    ARTHRITIS AND RHEUMATISM, 2003, 48 (09): : S516 - S516
  • [33] Early intravenous gamma-globulin treatment for Kawasaki disease: the nationwide surveys in Japan
    Wanitkun, S
    JOURNAL OF PEDIATRICS, 2005, 146 (01): : 149 - 150
  • [34] PENTOXIFYLLINE AND INTRAVENOUS GAMMA-GLOBULIN COMBINATION THERAPY FOR ACUTE KAWASAKI-DISEASE
    FURUKAWA, S
    MATSUBARA, T
    UMEZAWA, Y
    MOTOHASHI, T
    INO, T
    YABUTA, K
    EUROPEAN JOURNAL OF PEDIATRICS, 1994, 153 (09) : 663 - 667
  • [35] Early intravenous gamma-globulin treatment for Kawasaki disease: The nationwide surveys in Japan
    Muta, H
    Ishii, M
    Egami, K
    Furui, J
    Sugahara, Y
    Akagi, T
    Nakamura, Y
    Yanagawa, H
    Matsuishi, T
    JOURNAL OF PEDIATRICS, 2004, 144 (04): : 496 - 499
  • [36] Randomized Controlled Study of Intravenous Gamma-globulin Products in Treatment of Kawasaki Disease
    Hiromi Muta
    Masahiro Ishii
    Yoko Sugahara
    Teiji Akagi
    Hirohisa Kato
    Pediatric Research, 2003, 53 : 181 - 181
  • [37] THE TREATMENT OF KAWASAKI SYNDROME WITH INTRAVENOUS GAMMA-GLOBULIN
    NEWBURGER, JW
    TAKAHASHI, M
    BURNS, JC
    BEISER, AS
    CHUNG, KJ
    DUFFY, CE
    GLODE, MP
    MASON, WH
    REDDY, V
    SANDERS, SP
    SHULMAN, ST
    WIGGINS, JW
    HICKS, RV
    FULTON, DR
    LEWIS, AB
    LEUNG, DYM
    COLTON, T
    ROSEN, FS
    MELISH, ME
    NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (06): : 341 - 347
  • [38] Intravenous Immunoglobulin for the Treatment of Kawasaki Disease
    Shulman, Stanford T.
    PEDIATRIC ANNALS, 2017, 46 (01): : E25 - E28
  • [39] Intravenous immunoglobulin for the treatment of Kawasaki disease
    Broderick, Cathryn
    Kobayashi, Shinobu
    Suto, Maiko
    Ito, Shuichi
    Kobayashi, Tohru
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2023, (01):
  • [40] Intravenous immunoglobulin, pharmacogenomics, and Kawasaki disease
    Kuo, Ho-Chang
    Hsu, Yu-Wen
    Wu, Mei-Shin
    Chien, Shu-Chen
    Liu, Shih-Feng
    Chang, Wei-Chiao
    JOURNAL OF MICROBIOLOGY IMMUNOLOGY AND INFECTION, 2016, 49 (01) : 1 - 7